Regunyl LCa 4.25 peritoneal dialysis solution

Regunyl LCa 4.25 peritoneal dialysis solution, containing Defibrotide sodium and manufactured by Nippon Shinyaku, is an injectable drug. Defibrotide sodium is primarily used for the treatment of severe hepatic veno-occlusive disease (VOD) with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation. This product is supplied as 200mg 2.5mL x 1 bottle, with a YJ code of 3919401A1020.